Proteasome inhibitors market to reach $3.49 billion by 2030 at 10.2% CAGR, driven by increasing prevalence of pancreatic cancer.
Read More
Prostate Cancer Therapeutics Market Research 2026: Market Size, Trends, Segments And Growth Forecast
Prostate cancer therapeutics market to reach $19.25 billion by 2030 at 8.4% CAGR, driven by increasing incidence of prostate cancer.
Read More
Prostate cancer drugs market to reach $26.15 billion by 2030 at 6.2% CAGR, driven by increasing men geriatric population.
Read More
Propranolol drug market to reach $1.41 billion by 2030 at 5.2% CAGR, driven by growing prevalence of cardiovascular diseases.
Read More
Programmed death (PD)-1 non-small cell lung cancer market to reach $41.45 billion by 2030 at 8.5% CAGR, driven by increasing adoption of personalized treatments.
Read More
Progesterone market to reach $3.54 billion by 2030 at 14.5% CAGR, driven by increasing prevalence of hormonal disorders.
Read More
Process analytical technology market to reach $5.4 billion by 2030 at 9.8% CAGR, driven by rising demand for personalized medicine.
Read More
Primary progressive multiple sclerosis treatment market to reach $2.18 billion by 2030 at 13.5% cagr, driven by growing demand for effective treatments for chronic & complex neurological conditions.
Read More
Primary myelofibrosis market to reach $1.14 billion by 2030 at 6.2% cagr, driven by increasing prevalence of myelofibrosis due to aging populations.
Read More
Primary cell culture market to reach $14.54 billion by 2030 at 13.1% cagr, driven by increasing prevalence of chronic diseases and rising demand for advanced research models.
Read More